Eli Lilly Stock Rises; Mounjaro, Zepbound Blow Past Expectations

October 30, 2025

•

1 min read

•

Investor's Business Daily

Eli Lilly stock rose Thursday after the drugmaker easily topped third-quarter forecasts on the back of its two biggest drugs.

Pharmaceutical behemoth Eli Lilly (LLY) smashed Wall Street's third-quarter expectations and raised its full-year outlook Thursday, thanks to its diabetes and obesity treatments. "Arguably the strongest print across 3Q so far," Cantor analyst Carter ... [3390 chars]

Read Original Article

Source: Investor's Business Daily

Visit Source

Share this article

Twitter Facebook

Back to general news